Misconduct Office Vows To Keep Actions Secret

The new HHS unit resists pressure to reveal the names of the biomedical scientists it has found guilty of wrongdoing NEW ORLEANS -- The year-old Office of Scientific Integrity Review - responsible for resulting the cases of federally funded biomedical researchers accused of scientific misconduct - has meted out punishment to more than a dozen such researchers so far. But the head of that office said last month that he has no intention of making information pertaining to these cases available t

Written byJeffrey Mervis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


The new HHS unit resists pressure to reveal the names of the biomedical scientists it has found guilty of wrongdoing
NEW ORLEANS -- The year-old Office of Scientific Integrity Review - responsible for resulting the cases of federally funded biomedical researchers accused of scientific misconduct - has meted out punishment to more than a dozen such researchers so far. But the head of that office said last month that he has no intention of making information pertaining to these cases available to the public.

The issue of scientific misconduct is a contentious topic within the scientific community and in Congress. The debate has featured a long-running battle among the National Institutes of Health, Massachusetts Institute of Technology molecular biologist David Baltimore, and Rep. John Dingell (D-Mich.) over an investigation into allegations of improprieties in a 1986 Cell paper on antibody expression coauthored by Baltimore. Last August the Department of Health ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies